Identification of the promoter, genomic structure, and mouse ortholog of LGI1

被引:21
作者
Somerville, RPT [1 ]
Chernova, O [1 ]
Liu, SQ [1 ]
Shoshan, Y [1 ]
Cowell, JK [1 ]
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Ctr Mol Genet NB20, Cleveland, OH 44195 USA
关键词
D O I
10.1007/s0033500101280
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human LGI1 gene is a leucine-rich, repeat-containing gene that was cloned from the t(10:19) breakpoint of the T98G glioblastoma cell line. The LGI1 gene maps to 10q24, a region of peak LOH in malignant gliomas, and is inactivated during the transition from low to high-grade brain tumors. Here we report detailed studies of the genomic structure of the LGI1 gene and its promoter. We have also cloned and characterized the mouse lgil gene, which is 97% homologous to the human gene at the amino acid level and 91% homologous at the nucleotide level. LGI1 contains 8 exons, when each of the four leucine-rich repeat units is contained in an individual 72-bp exon. The cysteine-rich regions flanking the LRR and the single trans-membrane domain do not occupy individual exons. Approximately 5-kb of the genomic region 5' to LGI1 was sequenced, but conventional CAAT and TATA motifs were not present within this sequence. A 597-bp fragment of this 5' sequence was cloned upstream of a promoterless luciferase gene and was shown to be sufficient to drive transcription. SSCP analysis of the coding region of LGI1 in 20 glioblastomas and five cell lines did not reveal any mutations. Because LGI1 expression is considerably downregulated in gliomas, we also investigated whether this was owing to changes in the methylation status of the promoter. Southern blot analysis and 5-azacytidine treatment did not show any appreciable difference in methylation status between normal brain and glioblastomas.
引用
收藏
页码:622 / 627
页数:6
相关论文
共 43 条
[1]  
[Anonymous], 1982, MOL CLONING LAB MANU
[2]  
Boström J, 1998, CANCER RES, V58, P29
[3]   MOLECULAR AND GENETIC-CHARACTERIZATION OF THE DROSOPHILA TARTAN GENE [J].
CHANG, Z ;
PRICE, BD ;
BOCKHEIM, S ;
BOEDIGHEIMER, MJ ;
SMITH, R ;
LAUGHON, A .
DEVELOPMENTAL BIOLOGY, 1993, 160 (02) :315-332
[4]   Molecular definition of chromosome translocations involving 10q24 and 19q13 in human malignant glioma cells [J].
Chernova, O ;
Cowell, JK .
CANCER GENETICS AND CYTOGENETICS, 1998, 105 (01) :60-68
[5]   A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors [J].
Chernova, OB ;
Somerville, RPT ;
Cowell, JK .
ONCOGENE, 1998, 17 (22) :2873-2881
[6]   PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas [J].
Chiariello, E ;
Roz, L ;
Albarosa, R ;
Magnani, I ;
Finocchiaro, G .
ONCOGENE, 1998, 16 (04) :541-545
[7]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[8]   Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas [J].
Davies, MPA ;
Gibbs, FEM ;
Halliwell, N ;
Joyce, KA ;
Roebuck, MM ;
Rossi, ML ;
Salisbury, J ;
Sibson, DR ;
Tacconi, L ;
Walker, C .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1542-1548
[9]   PTEN mutations in gliomas and glioneuronal tumors [J].
Duerr, EM ;
Rollbrocker, B ;
Hayashi, Y ;
Peters, N ;
Meyer-Puttlitz, B ;
Louis, DN ;
Schramm, J ;
Wiestler, OD ;
Parsons, R ;
Eng, C ;
von Deimling, A .
ONCOGENE, 1998, 16 (17) :2259-2264
[10]  
FISHER LW, 1991, J BIOL CHEM, V266, P14371